MATTHEW GANDY: Open Payments
NPI 1104525567 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,865 in 102 payments from 19 companies in 2025. Trend: 2023 $1,317 · 2024 $1,732 · 2025 $2,865
Food & beverage: $2,481Travel & lodging: $384
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 5 | $753 |
| Novartis Pharmaceuticals Corporation | 19 | $314 |
| Shockwave Medical, Inc | 2 | $285 |
| E.R. Squibb & Sons, L.L.C. | 17 | $248 |
| Amgen Inc. | 15 | $229 |
| Boston Scientific Corporation | 2 | $171 |
| Merck Sharp & Dohme LLC | 9 | $164 |
| PFIZER INC. | 7 | $136 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $116 |
| Novo Nordisk Inc | 5 | $96 |
Products named: LEQVIO, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, REPATHA, CAMZYOS, VERQUVO, General - Vascular Intervention, LifeVest, ELIQUIS.
Industry payments across TX — which companies pay providers there.
